Related by context. All words. (Click for frequent words.) 77 urothelial carcinoma 75 prostate carcinoma 74 mucinous 74 LHRH receptor positive 74 prostate cancer CaP 74 Lymph node 74 extracapsular extension 73 metastatic lymph nodes 73 node metastases 73 prostate carcinomas 73 Papillary 73 cervical lymph nodes 73 nonmetastatic 73 endobronchial 73 precursor lesions 73 pancreatic prostate 73 liver metastasis 73 invasive ductal 73 lymph node metastasis 73 pT3 72 lymph node involvement 72 NMIBC 72 colorectal neoplasms 72 invasive carcinoma 72 urothelial cancer 72 pT2 72 histological subtype 72 leiomyomas 72 hyperplastic 72 breast carcinoma 71 leiomyoma 71 unresectable tumors 71 pulmonary metastases 71 invasive lobular 71 ovarian carcinoma 71 pulmonary metastasis 71 ductal carcinomas 71 neoplastic lesions 71 adenomatous 71 gastric adenocarcinoma 71 malignant ovarian 71 esophagogastric junction 71 histopathologic examination 71 hypervascular 71 atypical hyperplasia 70 colorectal carcinoma 70 arteriography 70 lymphomas leukemias 70 percutaneous biopsy 70 peritoneal carcinomatosis 70 endometrial carcinoma 70 HER2 expression 70 polypoid 70 colorectal adenocarcinoma 70 axillary node 70 metachronous 70 nodal metastases 70 esophagogastric 70 lymphovascular invasion 70 HER2 positive cancers 70 thyroid carcinoma 70 metaplasia 70 surgically resected 70 Immunohistochemical analysis 70 sarcomatoid 70 operable breast cancer 70 locoregional recurrence 70 lung metastasis 70 histologic subtype 70 renal cell carcinomas 70 hematopoietic cancers 70 distant metastasis 70 transabdominal 70 renal tumors 70 retroperitoneal 70 lymph node metastases 70 thyroid nodules 70 renal carcinoma 70 mediastinal lymph nodes 70 hamartoma 70 HNSCC 70 angiographically 70 malignant ascites 69 malignant neoplasm 69 tumor histology 69 colorectal adenoma 69 Radical prostatectomy 69 ovarian malignancy 69 thymectomy 69 metastatic bladder 69 lobular carcinoma 69 neoadjuvant therapy 69 carotid plaques 69 radical prostatectomy RP 69 pancreatic adenocarcinoma 69 PSA nadir 69 skeletal metastases 69 gastric cardia 69 recurrent ovarian 69 axillary lymph nodes 69 ductal adenocarcinoma 69 cisplatin resistant 69 adrenalectomy 69 F FDG PET 69 hormone receptor negative 69 susceptibility loci 69 endoscopic ultrasonography 69 squamous cell carcinoma SCC 69 mesenteric 69 papillary renal cell carcinoma 69 cytoreductive surgery 69 metastatic lesions 69 thymoma 69 hypervascular tumors 69 seminal vesicle invasion 69 debulking surgery 69 tumor subtypes 69 serous ovarian cancer 69 pancreatic lung 69 ductal breast cancer 69 SSc 69 precancerous condition 69 pretransplant 69 FDG-PET/CT 69 pelvic lymphadenectomy 69 pancreatic carcinoma 69 intact parathyroid hormone 69 pathologic examination 69 Hurthle cell 69 precancerous cervical 69 node metastasis 69 mutated K ras 69 intraoperative complications 69 Adenomas 69 neoplastic cells 69 advanced adenomas 69 Immunohistochemical staining 69 oral squamous cell 69 biochemical relapse 69 advanced neoplasia 69 intestinal metaplasia 69 T1c 69 colonic polyps 68 neoplasias 68 metastatic malignant 68 proximal colon 68 prostate cancer PCa 68 premalignant lesions 68 epithelial tumors 68 pathologic diagnosis 68 histologically confirmed 68 wedge resection 68 contralateral breast 68 micrometastasis 68 chemoresistant 68 extramedullary 68 lung carcinomas 68 neuritic 68 obstructive coronary artery 68 metastatic gastric 68 bile duct cancers 68 carcinomatosis 68 transthoracic 68 histological diagnosis 68 axillary lymph node 68 HER2 overexpression 68 gastric carcinoma 68 appendiceal 68 gastrointestinal stromal tumors GISTs 68 transesophageal echocardiography 68 normal karyotype 68 peritoneal cancer 68 nonmelanoma skin cancers 68 squamous carcinoma 68 T1a 68 GISTs 68 cervical lymph node 68 cytologic 68 mammographically 68 sonographically guided 68 underwent resection 68 adnexal mass 68 testicular tumors 68 carcinoids 68 Squamous 68 CIN2 + 68 Histopathologic examination 68 liver resection 68 histologically proven 68 hyperplastic polyps 68 sentinel lymph node biopsy 68 TRUS biopsy 68 grade squamous intraepithelial 68 oncologic outcomes 68 epididymal 68 rebleeding 68 pleomorphic 68 urolithiasis 68 breast endometrial 68 resectable 68 malignant prostate 68 PCa 68 needle aspiration 68 benign uterine 68 histopathological 68 sonographic appearance 68 endometrioid 68 distant metastases 68 hepatic lesions 68 HER2 amplification 68 hypermethylated 68 urothelial 68 serrated polyps 68 basal cell skin 68 submucosal 68 Histological examination 68 biliary tract 68 perineural invasion 68 preoperative PSA 68 ultrasonographic 68 ovarian pancreatic 68 paragangliomas 68 Mitomycin C 68 pelvic lymph nodes 68 biochemical recurrence 68 perioperative complications 68 malignant nodules 67 pituitary adenomas 67 calculi 67 metastatic neuroendocrine tumors 67 osteosarcomas 67 scintigraphic 67 malignant pleural mesothelioma 67 tumoral 67 diagnostic biomarker 67 Computed tomography 67 sonographically 67 tumor necrosis 67 cystoscopic 67 extracranial 67 parenchymal 67 Endometrial 67 papillary carcinoma 67 hepatocellular carcinomas 67 oropharyngeal 67 adenocarcinomas 67 cystic lesions 67 Leydig cell 67 atrophic gastritis 67 varices 67 prospective multicenter study 67 VATS lobectomy 67 Univariate analysis 67 lesional 67 mediastinal 67 Prognostic factors 67 HRCT 67 CIN3 67 cerebral angiography 67 squamous intraepithelial lesions 67 thrombocytopenic 67 gadolinium enhanced 67 resected tumors 67 intrahepatic 67 eccrine 67 Subgroup analysis 67 bony metastases 67 pCR 67 splenic 67 bladder tumors 67 KRAS oncogene 67 artery stenosis 67 renal pelvis 67 clinically localized prostate 67 endometrial hyperplasia 67 biliary tract cancer 67 axilla 67 adenomatous polyp 67 malignant polyps 67 Neoadjuvant chemotherapy 67 colorectal gastric 67 advanced adenoma 67 immunocompetent 67 pulmonary dysfunction 67 SLNB 67 lobular carcinomas 67 malignant lymphoma 67 glomerular 67 BRCA mutation carriers 67 bronchoalveolar lavage 67 molecular abnormalities 67 distal colon 67 endometrial cancers 67 decompensated cirrhosis 67 hormone receptor status 67 ADPKD 67 vestibular schwannomas 67 immunohistochemical 67 fibrin deposition 67 basal cell carcinoma BCC 67 ductal cancer 67 CYT# potent vascular disrupting 67 situ LCIS 67 spontaneous regression 67 urothelial bladder cancer 67 neointimal 67 tumorigenicity 67 thyroid nodule 67 desmoplastic 67 pleural fluid 67 parathyroid 67 TNF blocker therapy 67 recurrent metastatic 67 prostate bladder 67 nonischemic 67 FDG uptake 67 benign neoplasms 67 duplex ultrasonography 67 colonoscopic 67 transarterial 67 microsatellite instability 67 adjuvant radiotherapy 67 helical CT 67 Adjuvant chemotherapy 67 adenomatous polyps 67 benign nodules 67 localized renal 67 clinicopathological 67 immunohistochemical analysis 67 VEGF expression 67 invasive carcinomas 67 endocervical 67 cutaneous melanoma 67 bronchoalveolar lavage BAL 67 pre cancerous lesion 67 pheochromocytoma 67 postoperative morbidity 67 castrate resistant 67 extrapulmonary 67 choroidal neovascularization 67 prostate adenocarcinoma 67 myeloperoxidase 67 pre malignant lesions 67 HIV HCV coinfected 67 antiangiogenic therapy 67 micrometastases 67 BRCA1 BRCA2 67 multivariate analyzes 66 core needle biopsies 66 pseudotumor 66 axillary dissection 66 EGFR mutant 66 immunostaining 66 hypointense 66 Cystoscopy 66 metastatic pancreatic 66 haematologic 66 Surgical excision 66 esophageal gastric 66 tumor subtype 66 multicentric 66 aneurysmal 66 lobular 66 colorectum 66 hamartomas 66 transvaginal sonography 66 completely resected 66 carcinoid tumor 66 Colon polyps 66 epithelial ovarian 66 Sentinel node biopsy 66 molecular subtypes 66 colorectal polyp 66 radiographic findings 66 Surgical resection 66 LV dysfunction 66 transurethral resection 66 clinicopathological features 66 obstructive coronary 66 p# mutation 66 RRM1 66 squamous cell lung cancer 66 KRAS mutation 66 intraepithelial 66 radioiodine therapy 66 precancerous polyp 66 pAkt 66 MGUS 66 bladder ovarian 66 metastatic lesion 66 seminal vesicle 66 chemoembolization 66 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 66 prognostic indicator 66 eosinophil count 66 carotid stenosis 66 schwannomas 66 BRCA deficient 66 lung nodule 66 baseline LDH 66 primary hyperparathyroidism 66 stratifying patients 66 orthotopic 66 uterine tumors 66 colorectal tumor 66 neoplasm 66 Subgroup analyzes 66 prostate pancreatic 66 ultrasonographic examination 66 intraductal 66 renal scarring 66 etiologic 66 bronchogenic carcinoma 66 BRAF V#E mutation 66 cytoreduction 66 pancreatic endocrine 66 K ras mutations 66 LVNC 66 intratumoral 66 urethral stricture 66 visceral metastases 66 HGPIN 66 lumbar disk herniation 66 esophageal carcinoma 66 neuroendocrine cancers 66 medically inoperable 66 esophageal squamous cell carcinoma 66 deep venous thromboses 66 Histologic 66 specific antigen PSA 66 GIST tumors 66 node dissection 66 intracerebral 66 granulomatous 66 sleeve lobectomy 66 cardiac troponin T 66 lymphatic tissue 66 adrenocortical cancer 66 Legg Calvé Perthes disease 66 necrotic core 66 CD# expression [001] 66 epithelioid 66 lactate dehydrogenase 66 colon rectal 66 Histologically 66 proton MR spectroscopy 66 metastatic malignant melanoma 66 dysplastic lesions 66 submandibular gland 66 aerodigestive tract 66 histopathologic diagnosis 66 osteoid 66 embolizations 66 antiproliferative effects 66 TMPRSS2 ERG fusion 66 transitional cell carcinoma 66 cholelithiasis 66 prognostic variables 66 SUVmax 66 core needle biopsy 66 lymphocytosis 66 para aortic 66 Genetic variants 66 peritoneal fluid 66 fibroma 66 lung resection 66 beta1 integrin 66 peritumoral 66 salpingo oophorectomy 66 lymphadenopathy 66 detecting precancerous 66 keloid scarring 66 pulmonary artery banding 66 transrectal ultrasound guided 66 osteoid osteoma 66 neoplasms 66 lung nodules 66 histologic examination 66 nasopharyngeal carcinoma 66 allogeneic HSCT 66 neovascular 66 seminoma 66 nephron sparing surgery 66 retransplantation 66 cytotoxic therapies 66 EGFR mutation positive 66 epithelial ovarian cancer 66 progesterone receptor negative 66 radiotherapy RT 66 nephrogenic 66 histological subtypes 66 recurrent glioblastoma multiforme 65 spinal metastases 65 biliary obstruction 65 HER2 positivity 65 nonmelanoma 65 ductal 65 endocrine therapies 65 thromboembolic disease 65 metastatic colorectal 65 keloid scars 65 tryptase 65 Squamous cell 65 Estrogen Receptor 65 ovarian endometrial 65 trophoblast cells 65 mesotheliomas 65 bronchoalveolar 65 cytoreductive nephrectomy 65 ASCUS 65 florbetaben 65 FDG PET imaging 65 atherothrombotic 65 preoperative chemotherapy 65 cardiac repolarization 65 testicular cancers 65 intimal hyperplasia 65 Candida infection 65 lymphocytic 65 subclinical disease 65 TIMP 65 lipomas 65 hypoxia induced 65 intraluminal 65 cancer mCRC 65 postoperative chemotherapy 65 ALK inhibitors 65 occlusive disease 65 localized prostate 65 immunohistochemical staining 65 suppurative 65 hepatic cirrhosis 65 haematuria 65 nonalcoholic steatohepatitis 65 gastroduodenal 65 surgically resectable 65 breast cancer subtypes 65 cervical intraepithelial neoplasia 65 neuroendocrine carcinoma 65 prognostic biomarker 65 endoscopic retrograde 65 Circulating tumor cells 65 adjuvant therapies 65 cervical neoplasia 65 postoperative mortality 65 malignant lymphomas 65 clinico pathological 65 B7 H3 65 benign polyps 65 myxoid 65 syngeneic 65 airway hyperresponsiveness 65 prognostic indicators 65 carcinoid 65 Heavy menstrual bleeding 65 Multivariate analyzes 65 intrathoracic 65 total thyroidectomy 65 cell carcinomas 65 histologically 65 glomerular filtration 65 metastatic prostate 65 multivariate Cox 65 Metastases 65 uterine cervix 65 clinically detectable 65 testicular germ cell 65 atherosclerotic lesion 65 adenoma 65 troponin T 65 Chronic pancreatitis 65 Sezary syndrome 65 neoplastic 65 endoscopic resection 65 incomplete revascularization 65 systemic amyloidosis 65 percutaneous drainage 65 mycosis fungoides 65 nondiabetic patients 65 resections 65 malignant lesions 65 locoregional 65 Histological 65 MALT lymphoma 65 NSCLC tumors 65 seminomas 65 oesophageal adenocarcinoma 65 dysplastic 65 lung resections 65 perioperative morbidity 65 chemoradiation therapy 65 idiopathic pulmonary 65 chromosomal mutations 65 prostatic 65 poorer prognosis 65 mTOR inhibitors 65 benign noncancerous 65 occult metastases 65 Sjögren syndrome 65 systolic dysfunction 65 metastatic adenocarcinoma 65 CP CPPS 65 metastatic renal 65 malignant growths 65 PCA3 gene 65 nonalcoholic steatohepatitis NASH 65 lichen planus 65 SIADH 65 cTnI 65 meningeal 65 elevated IOP 65 intestinal polyps 65 postoperative infection 65 hilar 65 adjuvant cisplatin 65 thrombo embolic 65 histopathologic findings 65 tunica vaginalis 65 clinicopathologic 65 serum urate levels 65 lung metastases 65 histologic 65 prostate abnormalities 65 opacification 65 extranodal 65 hypertrophic scars 65 neovascularization 65 neurofibromas 65 tumors GIST 65 graft occlusion 65 arteriolar 65 ischemic lesions 65 neoplasia 65 Fine needle aspiration 65 intima media thickness 65 plexiform 65 bone scintigraphy 65 bladder cancers 65 hemorrhagic complications 65 EUS FNA 65 astrocytomas 65 pericardial effusion 65 ductal lobular 65 non resectable metastatic 65 urine cytology 65 BCR ABL mutations 65 angiosarcoma 65 sinonasal 65 pain palliation 65 vascular lesion 65 underwent surgical resection 65 premalignant 65 cervical carcinoma 65 pelvic malignancies 65 sentinel node 65 perianal 65 ovarian lung 65 macroalbuminuria 65 sentinel lymph nodes 65 cerebrospinal fluid CSF 65 BRAF V#E 65 carotid artery blockage 65 FGFR2 gene 65 bullous 65 kidney cysts 65 transrectal ultrasonography 65 computed tomographic 65 ovarian cervical 65 benign prostatic hyperplasia enlarged 65 osteolytic 65 axillary nodes 65 melanocytic nevi 65 MYCN amplification 65 extracapsular 65 transfusion syndrome 65 oligodendrogliomas 65 supratentorial 65 Multivariate logistic regression 65 histologies 65 Preoperative 65 Adjuvant therapy 65 Hashimoto thyroiditis 65 hyperparathyroidism 65 heparanase 64 Doppler sonography 64 portal vein thrombosis 64 carcinoid tumors 64 cellularity 64 nonsmall cell lung cancer 64 tamoxifen Nolvadex ® 64 lymphadenectomy 64 androgen dependent 64 neurologic complications 64 tracer uptake 64 excisional biopsy 64 myomas 64 ERK signaling 64 neurosensory 64 anaplastic 64 GSTP1 64 transmural 64 hydronephrosis 64 extrapleural pneumonectomy 64 repigmentation 64 autonomic dysfunction 64 concurrent chemoradiation 64 thrombi 64 paraganglioma 64 acute myeloid 64 upper endoscopy 64 proliferative retinopathy 64 % CI #.#-#.# [008] 64 hepatorenal syndrome 64 microvessel density 64 adrenocortical 64 variceal hemorrhage 64 choroidal 64 vascularisation 64 neovascularisation 64 cholangiocarcinoma 64 chest radiographs 64 myocardial necrosis 64 prognostic markers 64 lymph node biopsies 64 microvessel 64 gefitinib Iressa 64 polyps growths 64 T2 weighted images 64 lung esophageal 64 demonstrated antitumor activity 64 mediastinitis 64 efaproxiral 64 transurethral 64 Genetic mutation 64 pancreatic colon 64 #.#ng/ml 64 endoscopic ultrasound 64 venous malformations 64 gastric cancers 64 intraperitoneally 64 GPC5 64 uterus fallopian tubes 64 cytological 64 premalignant lesion 64 MAPK pathway 64 papillary 64 myxoma 64 Basal Cell 64 Ultrasonographic 64 Stage IIB 64 orchitis 64 thyroglobulin 64 gastroesophageal junction 64 troponins 64 perioperatively 64 #F FDG PET 64 spiral computed tomography 64 TT genotype 64 radical cystectomy 64 β blockers 64 malignant neoplasms 64 antiangiogenic agents 64 renal parenchyma 64 HER2 neu 64 obese postmenopausal 64 oesophageal 64 relapsed MM 64 osteochondroma 64 neoadjuvant 64 thyroid peroxidase 64 HBeAg negative 64 P cadherin 64 metastatic ovarian cancer 64 pleurodesis 64 p# biomarker 64 ADVEXIN therapy 64 esophageal resection 64 FDG PET 64 Chlamydia trachomatis infection 64 thoracic aortic aneurysms 64 nodular lesions 64 Microarray analysis 64 subependymal giant cell 64 biochemical abnormalities 64 glaucomatous 64 tumor excision 64 pulmonary resection 64 chlamydial 64 cystectomy 64 gastric varices 64 pancreatic duct 64 LRP5 64 histopathologic 64 undescended testes 64 Helicobacter infection 64 kidney urologic 64 uveal melanoma 64 vulvar intraepithelial neoplasia 64 adverse cytogenetics 64 fulminant hepatic failure 64 SNP rs# [002] 64 antiphospholipid antibodies 64 androgen ablation 64 rhabdoid 64 acute aortic dissection 64 digital subtraction angiography 64 oncogenic mutations 64 osteopenic 64 Hepatocellular Carcinoma HCC 64 infiltrating ductal carcinoma 64 PAOD 64 carcinoma HCC 64 hematological relapse 64 pulmonary alveolar 64 ADAMTS# 64 CTEPH 64 pancreatic ductal 64 Radiofrequency ablation 64 plasmacytoid 64 germline mutations 64 pelvic ultrasound 64 Plain radiographs 64 lung ovary 64 elevated LDH 64 EBUS FNA 64 biliary tree 64 genomic biomarker 64 adenoma detection 64 Her2 positive 64 CT angiography CTA 64 renal cysts 64 chemoradiotherapy 64 sclerosing 64 abnormal clotting 64 fallopian tube carcinoma 64 recurrent glioblastoma multiforme GBM 64 underarm lymph nodes 64 Fas ligand 64 lymphangiogenesis 64 prostatic tissue 64 recurrent DVT 64 leukocytosis 64 alveolar epithelial cells 64 histologic findings 64 HER2 receptor 64 lung adenocarcinomas 64 endotoxemia 64 DCIS ductal carcinoma 64 atherosclerotic lesions 64 KRAS mutations 64 monoclonal gammopathy 64 T1DM 64 prostate colon 64 chronic thromboembolic pulmonary 64 MDCT angiography 64 computed tomographic scans 64 colorectal carcinomas 64 FluCAM arm 64 biliary stones 64 endometrial tumors 64 cardiac dysfunction 64 neovascular diseases 64 oncological outcomes 64 basal cell cancers 64 chest radiograph 64 N. gonorrhoeae 64 hepatocellular carcinoma liver 64 lung fibrosis 64 locoregional disease 64 taxane therapy 64 thermogram 64 smoldering myeloma 64 latent celiac disease 64 fundus photography 64 SPECT CT imaging 64 symptomatic intracranial 64 retrospective cohort 64 Thal Dex 64 taxane resistant 64 T2 lesions 64 Histopathologic 64 hepatocellular 64 postoperative pulmonary 64 thyrotropin levels 64 ß blockers 64 underwent radical prostatectomy 64 Gorlin syndrome 64 tumor xenograft models 64 nodular melanoma 64 thoracoscopic lobectomy 64 GI bleeds 64 postoperative delirium 64 estrogen receptor ER 64 Duodenal 64 thyrotropin 64 radiochemotherapy 64 pelvic irradiation 64 TNM staging 64 chemosensitivity 64 coronary stenosis 64 bronchioloalveolar carcinoma 64 pancreatic ductal adenocarcinoma 64 hypercalciuria 64 seropositivity 64 oral Hycamtin 64 pulmonary toxicity 64 malignant pancreatic 64 recanalization 64 Lp PLA 2 64 hyperacute 64 bronchial epithelial cells 64 tumor nodules 64 pleural effusions 64 chromosomal rearrangement 64 dermal collagen 64 abdominal hysterectomy 64 murine model 64 HepG2 cells 64 genes differentially expressed 64 choroidal melanoma 64 transesophageal 64 bilateral oophorectomy 64 ABCB1 64 luminal 64 intracerebral haemorrhage 64 curability 64 surgical debulking 64 percutaneous interventions 64 trophoblastic 64 hypoperfusion 64 tracheal intubation 64 cytogenic 64 liver metastases 64 pulmonary nodules 64 nodal dissection 64 Sentinel lymph node 64 papillomas 64 nonproliferative 64 alpha1 antitrypsin deficiency 64 chronic periodontitis 64 postoperative radiotherapy 64 MMP# 64 neoadjuvant treatment 64 PSADT 64 CC genotype 64 gynecologic malignancy 63 echogenicity 63 cranial irradiation 63 mediastinum 63 predisposing factor 63 breast pancreatic 63 IDH mutations 63 Enzastaurin 63 neurocognitive impairment 63 distinct subtypes 63 computed tomography angiography 63 renal cortical 63 coronary vessels 63 small lymphocytic lymphoma 63 plasma kallikrein 63 postoperative complication 63 serum GGT 63 cryptogenic 63 vesicoureteral reflux VUR 63 endosonography 63 mutated BRAF gene 63 polyp recurrence 63 Breslow thickness 63 axillary lymph node dissection 63 micro calcifications 63 interstitial fibrosis 63 OGG1 63 perfusion defects 63 plasma pharmacokinetics 63 cerebral microbleeds 63 dysplastic nevi 63 Lung transplantation 63 Uterine cancer 63 abdominal ultrasound 63 ipsilateral breast 63 genetic loci 63 spirometric 63 biopsy specimen 63 gene polymorphisms 63 lobular breast cancer 63 mitomycin C 63 mycophenolate 63 polypoid lesions 63 somatostatin receptors 63 C. pneumoniae 63 ano genital warts 63 variceal 63 echogenic 63 intraventricular 63 arterial calcification 63 papillary thyroid carcinoma 63 F FDG uptake 63 pretreatment serum 63 diabetes mellitus DM